Literature DB >> 30489453

Hydrogen sulfide improves vascular repair by promoting endothelial nitric oxide synthase-dependent mobilization of endothelial progenitor cells.

Qingsong Hu1,2, Xiao Ke3,4, Tao Zhang2, Yangxin Chen1, Qingsheng Huang1, Bingqing Deng1, Shuanglun Xie1, Jingfeng Wang1, Ruqiong Nie1.   

Abstract

BACKGROUND: Endothelial progenitor cells (EPCs) play a crucial role in endothelial repair after arterial injury. Hydrogen sulfide (H2S) is a novel gasotransmitter that regulates vascular homeostasis.
METHOD: We investigated whether exogenous H2S could facilitate EPCs in repairing arterial injury.
RESULTS: Sodium hydrosulfide (NaHS), a precursor of H2S, promoted re-endothelialization and inhibited neointima formation in a rodent carotid artery injury model. Flow cytometric analysis revealed that NaHS treatment significantly increased the yield of EPCs after vascular injury. Furthermore, NaHS enhanced the capacity of EPCs to the luminal surface of injured arteries in wild-type mice, which had received a bone marrow transplantation from tie2-GFP donor mice. However, this enhancing effect was greatly attenuated in endothelial nitric oxide synthase knockout mice (eNOS). In-vitro incubation of human EPCs with NaHS not only increased the yield of EPCs, but also enhanced their adhesion and colony formation capacities. Treatment with an eNOS inhibitor (L-NAME) blocked the effects of NaHS on EPCs functions.
CONCLUSION: H2S enhances eNOS-dependent mobilization of bone marrow-derived EPCs and facilitates re-endothelialization following vascular injury.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30489453     DOI: 10.1097/HJH.0000000000001983

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  8 in total

Review 1.  Regulation of endothelial progenitor cell functions during hyperglycemia: new therapeutic targets in diabetic wound healing.

Authors:  Gui Wan; Yangyang Chen; Jing Chen; Chengqi Yan; Cheng Wang; Wenqing Li; Renqun Mao; Hans-Günther Machens; Xiaofan Yang; Zhenbing Chen
Journal:  J Mol Med (Berl)       Date:  2022-01-08       Impact factor: 4.599

2.  The effect of fluid shear stress in hydrogen sulphide production and cystathionine γ-lyase expression in human early endothelial progenitor cells.

Authors:  Qingsong Hu; Baojian Zhang; Yulong Liu; Yiqun Guo; Tao Zhang; Ruqiong Nie; Xiao Ke; Xiaobian Dong
Journal:  Ann Transl Med       Date:  2020-10

3.  SG1002 and Catenated Divalent Organic Sulfur Compounds as Promising Hydrogen Sulfide Prodrugs.

Authors:  Gabriel Gojon; Guillermo A Morales
Journal:  Antioxid Redox Signal       Date:  2020-06-11       Impact factor: 8.401

4.  MiR-92a regulates endothelial progenitor cells (EPCs) by targeting GDF11 via activate SMAD2/3/FAK/Akt/eNOS pathway.

Authors:  Hai-Tao Huang; Zhen-Chuan Liu; Kai-Qin Wu; Shao-Rui Gu; Tian-Cheng Lu; Chong-Jun Zhong; Yong-Xin Zhou
Journal:  Ann Transl Med       Date:  2019-10

5.  Role of the stromal cell derived factor-1 in the biological functions of endothelial progenitor cells and its underlying mechanisms.

Authors:  Yanping Cun; Bo Diao; Zhimin Zhang; Gang Wang; Jing Yu; Lianting Ma; Zhiguo Rao
Journal:  Exp Ther Med       Date:  2020-11-17       Impact factor: 2.447

Review 6.  Nitric Oxide-Releasing Platforms for Treating Cardiovascular Disease.

Authors:  Mingyue He; Deping Wang; Yumei Xu; Fangying Jiang; Jian Zheng; Yanlin Feng; Jimin Cao; Xin Zhou
Journal:  Pharmaceutics       Date:  2022-06-25       Impact factor: 6.525

Review 7.  Endothelial Progenitor Cells Dysfunctions and Cardiometabolic Disorders: From Mechanisms to Therapeutic Approaches.

Authors:  Anne-Christine Peyter; Jean-Baptiste Armengaud; Estelle Guillot; Catherine Yzydorczyk
Journal:  Int J Mol Sci       Date:  2021-06-22       Impact factor: 5.923

Review 8.  Hydrogen Sulfide in Bone Tissue Regeneration and Repair: State of the Art and New Perspectives.

Authors:  Laura Gambari; Brunella Grigolo; Francesco Grassi
Journal:  Int J Mol Sci       Date:  2019-10-22       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.